Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas
Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas
复制标题
DOI:
10.1111/j.1349-7006.1998.tb00502.x
复制
发表时间:
1998-11-01
期刊:
影响因子:
--
通讯作者:
Tahara, E
中科院分区:
文献类型:
--
作者:
Yasui, W;Tahara, H;Tahara, E
Telomerase activity is believed to be crucial for cellular immortality, which is considered to participate in the development of a majority of human cancers. Human telomerase reverse transcriptase (TERT) has recently been identified as a catalytic subunit of telomerase. We examined the expression of TERT and other telomerase components such as human telomerase RNA component (hTR, encoded by TERC) and human telomerase-associated protein (TEP1) by reverse transcription-polymerase chain reaction in human gastric carcinomas and non-neoplastic mucosa, in addition to measuring the telomerase activity. Of 20 gastric carcinomas examined, 18 (90%) and 18 (90%) showed increased expression of TERT and higher telomerase activity in comparison with corresponding non-neoplastic mucosa, respectively, Increased expression of hTR/TERC was also observed in 15 (75%) of the gastric carcinomas, Immunohistochemically, strong expression of TERT protein was detected in the nuclei of the tumor cells of all carcinoma tissues, while the expression of TERT in non-neoplastic mucosal cells as well as stromal elements (except lymphocytes) was weak or negative. These findings suggest that increased TERT expression associated with telomerase activity may serve as a novel marker for the diagnosis of stomach cancer.